Position in ALVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,954,551
+$225,142 QoQ
Shares Held
529,689
+5.1% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 72 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. ALVO ranks #29 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in ALVO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,954,551 | 529,689 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,729,409 | 504,201 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $124,397 | 24,249 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $200,286 | 24,455 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $171,072 | 18,758 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $203,379 | 21,032 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $284,550 | 21,508 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $20,337 | 1,709 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $53,114 | 4,368 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $3,678 | 301 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $77,027 | 8,446 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $466,171 | 60,229 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,437 | 499 | Shares | Defined | 2023-05-18 | |
| No filing history on record for this holder in this stock. | ||||||